Book contents
- Congenital Cardiac Anesthesia
- Congenital Cardiac Anesthesia
- Copyright page
- Dedication
- Contents
- Contributors
- Introduction
- Chapter 1 A Congenital Heart Disease Primer
- Section 1 Left-to-Right Shunts
- Section 2 Right-Sided Obstructive Lesions
- Section 3 Left-Sided Obstructive Lesions
- Chapter 14 Critical Aortic Stenosis
- Chapter 15 Aortic Stenosis
- Chapter 16 Subvalvular Aortic Stenosis
- Chapter 17 Supravalvular Aortic Stenosis
- Chapter 18 Hypertrophic Cardiomyopathy
- Chapter 19 Coarctation of the Aorta
- Chapter 20 Shone Complex
- Section 4 Complex Mixing Lesions
- Section 5 Single-Ventricle Physiology
- Section 6 Heart Failure, Mechanical Circulatory Support, and Transplantation
- Section 7 Miscellaneous Lesions and Syndromes
- Index
- References
Chapter 18 - Hypertrophic Cardiomyopathy
from Section 3 - Left-Sided Obstructive Lesions
Published online by Cambridge University Press: 09 September 2021
Book contents
- Congenital Cardiac Anesthesia
- Congenital Cardiac Anesthesia
- Copyright page
- Dedication
- Contents
- Contributors
- Introduction
- Chapter 1 A Congenital Heart Disease Primer
- Section 1 Left-to-Right Shunts
- Section 2 Right-Sided Obstructive Lesions
- Section 3 Left-Sided Obstructive Lesions
- Chapter 14 Critical Aortic Stenosis
- Chapter 15 Aortic Stenosis
- Chapter 16 Subvalvular Aortic Stenosis
- Chapter 17 Supravalvular Aortic Stenosis
- Chapter 18 Hypertrophic Cardiomyopathy
- Chapter 19 Coarctation of the Aorta
- Chapter 20 Shone Complex
- Section 4 Complex Mixing Lesions
- Section 5 Single-Ventricle Physiology
- Section 6 Heart Failure, Mechanical Circulatory Support, and Transplantation
- Section 7 Miscellaneous Lesions and Syndromes
- Index
- References
Summary
Hypertrophic cardiomyopathy is a common, autosomal dominant cardiac disease with heterogeneity of expression. Although predominantly an obstructive lesion, it is also characterized by dysrhythmias, diastolic dysfunction, and subendocardial ischemia. Knowledge of the pathophysiology of the disease is imperative in order to provide safe anesthetic care. A comprehensive preoperative evaluation is important in identifying high-risk patients with more malignant forms of the disease. This chapter reviews the abnormalities associated with hypertrophic cardiomyopathy. In addition, strategies to maintain normal sinus rhythm and blood pressure and to prevent catecholamine surges are discussed with specific reference to anesthetic agents and their effects in patients with hypertrophic cardiomyopathy.
Keywords
- Type
- Chapter
- Information
- Congenital Cardiac AnesthesiaA Case-based Approach, pp. 113 - 120Publisher: Cambridge University PressPrint publication year: 2021
References
References
Poliac, L. C., Barron, M. E., and Maron, B. J.. Hypertrophic cardiomyopathy. Anesthesiology 2006; 104 : 183–92.Google Scholar
Cooper, R. M., Raphael, C. E., Liebregts, M., et al. New developments in hypertrophic cardiomyopathy. Can J Cardiol 2017; 33: 1254–65.Google Scholar
Maron, B. J., Maron, M. S., and Semsarian, C.. Genetics of hypertrophic cardiomyopathy after 20 years: clinical perspectives. J Am Coll Cardiol 2012; 60: 705–15.CrossRefGoogle ScholarPubMed
Varnava, A. M., Elliott, P. M., Mahon, N., et al. Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy. Am J Cardiol 2001; 88: 275–79.CrossRefGoogle ScholarPubMed
Johansson, B., Morner, S., Waldenstrom, A., et al. Myocardial capillary supply is limited in hypertrophic cardiomyopathy: a morphological analysis. Int J Cardiol 2008; 126: 252–7.Google Scholar
Colan, S. D., Lipshultz, S. E., Lowe, A. M., et al. Epidemiology and cause-specific outcome of cardiomyopathy in children. Findings from the Pediatric Cardiomyopathy Registry. Circulation 2007; 115: 773–81.Google Scholar
Maron, M. S., Maron, B. J., Harrigan, C., et al. Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance. J Am Coll Cardiol 2009; 54: 220–8.Google Scholar
Gersh, B. J., Maron, B. J., Dearani, J. A., et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: Executive Summary, a Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardio 2011; 58: 2703–38.Google Scholar
Hreybe, H., Zahid, M., Sonel, A., et al. Noncardiac surgery and the risk of death and other cardiovascular events in patients with hypertrophic cardiomyopathy. Clin Cardiol 2006; 29: 65–8.Google Scholar
Norrish, B., Forshaw, N., Woo, C., et al. Outcomes following general anesthesia in children with hypertrophic cardiomyopathy. Arch Dis Child 2019; 104: 471–5.CrossRefGoogle ScholarPubMed
Dhillon, A., Khanna, A., Randhawa, M. S., et al. Perioperative outcomes of patients with hypertrophic cardiomyopathy undergoing non-cardiac surgery. Heart 2016; 102: 1627–32.Google Scholar
Crossley, G. H., Poole, J. E., Rozner, M. A., et al. The Heart Rhythm Society (HRS)/American Society of Anesthesiologists (ASA) Expert Consensus Statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors. Heart Rhythm 2011; 8: 1114–54.Google Scholar
Madigan, J. D., Choudhri, A. F., Chen, J., et al. C. Surgical management of the patient with an implanted cardiac device Ann Surg 1999; 230: 639–47.Google Scholar
Suggested Reading
Dhillon, A., Khanna, A., Randhawa, M. S., et al. Perioperative outcomes of patients with hypertrophic cardiomyopathy undergoing non-cardiac surgery. Heart 2016; 102: 1627–32.Google Scholar
Norrish, B., Forshaw, N., Woo, C., et al. Outcomes following general anesthesia in children with hypertrophic cardiomyopathy. Arch Dis Child 2019; 104: 471–75.CrossRefGoogle ScholarPubMed